A case of rhinocerebral mucormycosis with brain abscess drained by endoscopic endonasal skull base surgery by Uraguchi, Kensuke et al.
Medical Mycology Case Reports 30 (2020) 22–25
Available online 25 September 2020
2211-7539/© 2020 The Authors. Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
A case of rhinocerebral mucormycosis with brain abscess drained by 
endoscopic endonasal skull base surgery 
Kensuke Uraguchi a,b, Kenichi Kozakura b, Satoshi Oka c, Takaya Higaki a,*, Seiichiro Makihara d, 
Toshi Imai c, Akira Doi b, Tsuyoshi Ohta e, Shin Kariya a, Kazunori Nishizaki a 
a Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan 
b Department of Otorhinolaryngology, Kochi Health Sciences Center, Kochi, Japan 
c Department of Hematology and Blood Transfusion, Kochi Health Sciences Center, Kochi, Japan 
d Department of Otorhinolaryngology, Head and Neck Surgery, Kagawa Rosai Hospital, Kagawa, Japan 
e Department of Neurosurgery, Kochi Health Sciences Center, Kochi, Japan   





Endoscopic endonasal skull base surgery 
Acute monocytic leukemia 
A B S T R A C T   
A 70-year-old Japanese man undergoing remission induction therapy for acute monocytic leukemia (AML-M5b) 
developed fever and headache, and was started on antibiotics and liposomal amphotericin B (L-AMB). There was 
no improvement, and computed tomography and contrast-enhanced magnetic resonance imaging revealed acute 
rhinosinusitis and brain abscess. Successful endoscopic endonasal surgery was performed at this point, providing 
drainage for the rhinosinusitis and abscess. Histopathological findings showed the mucormycosis.   
1. Introduction 
Rhinocerebral mucormycosis is a rare but life-threatening fungal 
infection that usually occurs in immunocompromised patients [1], and 
brain abscess could develop from the sinus infection [2]. Rhinocerebral 
mucormycosis in the paranasal sinus has been treated by aggressive 
surgical debridement and antifungal drug therapy; however, it is diffi-
cult to decide the appropriate surgery for brain abscesses [3–6]. Here, 
we report a case of endoscopic endonasal skull base surgery performed 
for rhinocerebral mucormycosis with brain abscess. 
1.1. Case presentation 
A 70-year-old Japanese man with general malaise and pancytopenia 
was referred to the hematology department for evaluation. He had a past 
history of untreated diabetes and chronic renal disease. He was diag-
nosed with acute monocytic leukemia (AML-M5b) by bone marrow 
aspiration, and the cerebrospinal fluid (CSF) cytology was Class III. The 
patient was started on remission induction therapy with a combination 
of cytarabine and daunorubicin and received intrathecal chemotherapy 
aiming at prevention for relapse of central nervous system. 
On the 16th day from start of the remission induction therapy, 
although we had administrated antibiotic treatment with 1.5g/day 
meropenem and antifungal treatment with 150 mg/day micafungin for 
febrile neutropenia as empiric therapy, he had fever and headache. 
Laboratory tests revealed a white blood cell count of 150/μl (normal 
range: 3500–9000), hemoglobin level of 6.9 g/dl (normal range: 
13.4–17.4), platelet count of 20,000/μl (normal range: 
120,000–350,000), HbA1c level of 6.5% (normal range: 4.6–6.2), 
creatinine clearance of 28.1 ml/min (normal range: 76.0–140.3) in a 24- 
h urine collection test, C-reactive protein level of 10.57 mg/dl (normal 
range: 0.00–0.30), and procalcitonin of 0.84 ng/ml (normal range: 
<0.50). Moreover, the results for beta-D-glucan, which was 12.4 pg/ml 
(normal range: 0.00–20.0), and aspergillus galactomannan antigen in 
serum were negative. Two sets of blood culture test were negative. 
Therefore, we changed antibiotic treatment to 500 mg/day levofloxacin 
and changed the antifungal treatment to 2.5 mg/kg/day liposomal 
amphotericin B (L-AMB). 
On the 22nd day from start of the remission induction therapy, there 
was no improvement in clinical symptoms. Computed tomography and 
magnetic resonance imaging (MRI) showed a soft tissue shadow in the 
right ethmoid and sphenoid sinus (Fig. 1A), and a slight brain edema in 
the frontal lobe adjoining the paranasal shadow without bone erosion of 
the skull base. We suspected acute rhinosinusitis gave rise to intracranial 
lesions, and therefore changed treatment from levofloxacin to 4 g/day 
meropenem while also increasing the L-AMB dosage to 5 mg/kg/day. 
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The patient had persistent fever, intermittent headache and presented 
with a syndrome of inappropriate secretion of ADH (SIADH). On the 
contrary, the patient did not have nasal discharge, local skin ulceration 
and other neurologic symptoms. 
On the 32nd day from start of the remission induction therapy, 
contrast-enhanced MRI showed a brain abscess and extension of brain 
edema localized in the frontal lobe adjoined the skull base at the pos-
terior ethmoid sinus (Fig. 1B–D). An endoscopic examination of the 
nasal cavity revealed a normal membrane without necrotic tissue and 
nasal discharge. Laboratory tests revealed a white blood cell count of 
4430/μl, hemoglobin level of 8.2 g/dl, platelet count of 81,000/μl, and 
C-reactive protein level of 0.52 mg/dl, and beta-D-glucan level of 12.0 
pg/ml. Therefore, the patient was referred to the otolaryngology 
department and received emergency surgery on the same day. 
We performed endoscopic endonasal skull base surgery in coopera-
tion with a neurosurgeon (see in supplemental material). There was no 
necrotic membrane in the middle meatus and the maxillary, frontal, and 
anterior ethmoidal sinuses (Fig. 2A and B). The posterior ethmoidal 
sinus membrane appeared to be necrotic (Fig. 2C). In the sphenoid sinus, 
pus leaked out, and the membrane was light red without necrosis. With a 
navigation system, we drilled into the posterior ethmoid roof and 
exposed the dura mater (Fig. 2D), then resected the dura mater, and 
drained the brain abscess. The abscess had whitish-yellowish pus, which 
we washed with a saline solution (Fig. 2E). Although CSF leakage 
occurred, we stopped it by cauterizing the area between the dura mater 
and brain abscess wall (Fig. 2F). A biopsy was taken from the membrane 
in the anterior and posterior ethmoidal sinuses, membrane in the 
sphenoid sinus, dura mater and brain abscess wall. Pus from the sphe-
noid sinus and discharge from the brain abscess were also taken for 
culture tests. At the end of the intervention, we packed the nasal cavity 
with chitin-coated gauze. 
After the operation, we increased the L-AMB dosage to 10 mg/kg/ 
day on the assumption that the patient had rhinocerebral mucormycosis, 
considering his immunodeficiency and necrotic membrane. A histo-
pathological examination found broad, non-septate hyphae growing in 
almost all of the necrotic membrane, and hyphae branching and 
spreading at acute angles within the posterior ethmoidal sinus mem-
brane and brain abscess (Fig. 3A). Some hyphae invaded blood vessels in 
the membrane (Fig. 3B and C). The culture test results of the pus from 
the sphenoid sinus and brain abscess were negative. After diagnosing 
rhinocerebral mucormycosis with brain abscess, we suggested to the 
patient to use nasal irrigation with saline by himself, but he rejected this 
instruction. The postoperative course was uncomplicated, with neither 
CSF leakage nor meningitis, and he recovered from the fever and 
headache. On the 17th postoperative day (on the 49 day from start of the 
remission induction therapy), a bone marrow examination showed 
recurrence of AML-M5b. On the 21st postoperative day, MRI showed 
reduction of the brain abscess, the remaining brain edema, and air in the 
brain abscess. On the 30th postoperative day, the patient was started on 
azacytidine for the recurrence of AML-M5b. Afterward, on the 42nd 
postoperative day, the patient died from gram-negative septic shock due 
to an intestinal infection. 
2. Discussion 
The aggressive hallmarks of mucormycosis easily lead to high mor-
tality because of delays in diagnosis and incorrect treatment. Rhinoc-
erebral mucormycosis is the most common clinical presentation of 
mucormycosis, which is caused by inhalation of spores [7]. Mucormy-
cosis can spread from the paranasal sinus to extranasal sites such as skin, 
orbital, and brain lesions. Although the most frequent causes of brain 
abscesses are Streptococcus and Staphylococcus species [8], in immuno-
compromised patients the differential diagnosis of causative organisms 
is much broader. Mucormycosis may invade the central nervous system 
in 13.3–22% of cases with haematological disorders, and the most 
common form of invasive disease is rhino-orbital-cerebral mucormy-
cosis, reported in 33–49% of patients [2]. However, Therakathu et al. 
reported that brain abscess was rare, occurring in 2 out of 43 patients 
with rhino-orbital-cerebral mucormycosis [9]. The basic treatment for 
mucormycosis is a combination of aggressive surgical debridement and 
antifungal drug therapy such as with intravenous L-AMB [10]. Despite 
the aggressive surgical and antifungal drug treatment, mucormycosis 
has been a life-threating disease with a poorer prognosis than viral and 
bacterial infections [4]. Furthermore, surgery is sometimes impossible 
to perform in cases of disseminated mucormycosis or infected organs 
that are difficult to reach, such as certain parts of the brain [5]. 
In this reported case, because the brain abscess developed from acute 
rhinosinusitis in spite of antibiotic and antifungal therapy. The decision 
to perform the surgery came after discussions with a neurosurgeon, 
hematologist, and anesthetist. Although neurosurgery offered several 
more common approaches such as craniotomy and stereotactic aspira-
tion, we chose endoscopic endonasal skull base surgery for two reasons. 
First, the immunosuppressed patient was in poor general condition, so 
he could not tolerate craniotomy, and stereotactic aspiration could 
penetrate the abscess and lead to meningitis. Second, debridement was 
required for the sinusitis, which progressed to brain abscess by vascular 
invasion penetrating the skull base. The surgery was also expected to be 
easier to perform than other approaches because the brain abscess 
adjoined the skull base at the posterior ethmoid sinus. For these reasons, 
an endonasal approach was suitable for diagnosis and provided a less 
traumatic option [10]. 
Preoperatively, we planned to use a mucosal flap, fascia, and fat to 
seal any CSF leak that occurred, but also expected difficulties in using 
them for reconstruction because the packing for the brain abscess might 
be inappropriate and the mucosal flap might lead to necrosis by infec-
tion. If the vascularized mucosal flap was unsuccessful to seal CSF leak, 
we planned to use abdominal fat filling into cavity as plug and nasal 
packing for general compression temporarily. Actually, there was a 
small CSF leak from a crack between the dura mater and brain abscess 
wall during the operation, but we unexpectedly were able to stop the 
leak by cauterizing the crack and agglutinating cells. 
A few cases of brain abscess drained by endoscopic endonasal skull 
base surgery have been reported [11,12]. In the paper on invasive fungal 
sinusitis with brain abscess, a similar case caused by Aspergillus spp was 
discussed; the brain abscess that had spread from the sinusitis was 
drained by an endonasal trans-ethmoidal approach, though there was no 
Fig. 1. Preoperative CT and contrast-enhanced MRI: (A) CT showing acute rhinosinusitis without bone erosion; (B, C) gadolinium-contrasted T1-weighted image 
showing a brain abscess with a rim of peripheral enhancement localized in the frontal sinus adjoined the skull base at the posterior ethmoid sinus; (D) T2-weighted 
image showing brain edema in the frontal lobe around the brain abscess. 
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CSF leak and the aperture was left open for drainage [11]. As for 
mucormycosis, there were a few case reports of the skull base mucor-
mycosis without brain abscess resected by endoscopic endonasal skull 
base surgery. In these reports, mucormycosis spread to neighboring 
structure with bone erosion [13,14]. To our knowledge, this paper 
presents the first report of rhinocerebral mucormycosis with brain ab-
scess drained by endoscopic endonasal skull base surgery. In this case, 
brain abscess might have been developed from acute rhinosinusitis 
through vascular invasion penetrating the skull base without bone 
erosion. The advantage of this endonasal endoscopic surgery for brain 
abscess is that the procedure is minimally invasive and relatively simple 
to perform, so the surgery could be considered as a possible treatment 
for brain abscess. 
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